- Home
- SURG vs RNXT Comparison
SURG vs RNXT Comparison
Compare SURG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- RNXT
- Stock Information
- Founded
- SURG 2006
- RNXT 2012
- Country
- SURG United States
- RNXT United States
- Employees
- SURG N/A
- RNXT N/A
- Industry
- SURG Advertising
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- RNXT Health Care
- Exchange
- SURG Nasdaq
- RNXT Nasdaq
- Market Cap
- SURG 56.5M
- RNXT 44.6M
- IPO Year
- SURG N/A
- RNXT 2021
- Fundamental
- Price
- SURG $3.24
- RNXT $1.36
- Analyst Decision
- SURG Strong Buy
- RNXT Strong Buy
- Analyst Count
- SURG 1
- RNXT 2
- Target Price
- SURG $9.00
- RNXT $7.25
- AVG Volume (30 Days)
- SURG 106.8K
- RNXT 147.2K
- Earning Date
- SURG 08-12-2025
- RNXT 08-12-2025
- Dividend Yield
- SURG N/A
- RNXT N/A
- EPS Growth
- SURG N/A
- RNXT N/A
- EPS
- SURG N/A
- RNXT N/A
- Revenue
- SURG $40,029,467.00
- RNXT $240,000.00
- Revenue This Year
- SURG $57.76
- RNXT $3,186.05
- Revenue Next Year
- SURG $112.61
- RNXT $291.93
- P/E Ratio
- SURG N/A
- RNXT N/A
- Revenue Growth
- SURG N/A
- RNXT N/A
- 52 Week Low
- SURG $1.05
- RNXT $0.75
- 52 Week High
- SURG $3.47
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- SURG 61.40
- RNXT 49.29
- Support Level
- SURG $2.86
- RNXT $1.27
- Resistance Level
- SURG $3.31
- RNXT $1.42
- Average True Range (ATR)
- SURG 0.24
- RNXT 0.06
- MACD
- SURG 0.04
- RNXT -0.02
- Stochastic Oscillator
- SURG 80.49
- RNXT 25.06
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.